12.07.2015 Views

Download Update 11 - Update in Anaesthesia - WFSA

Download Update 11 - Update in Anaesthesia - WFSA

Download Update 11 - Update in Anaesthesia - WFSA

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

82<strong>Update</strong> <strong>in</strong> <strong>Anaesthesia</strong>TRICHLOROETHYLENE (“Trilene”)Physical properties: Boils at 87 o C (high), SVP at 20 o C:60 mmHg. Blood/Gas partition coefficient: 9 (high), MAC0.17%Advantages: Non-irritant. Safe. Good analgesia dur<strong>in</strong>gand after surgery. Cardiovascularly stable. Very cheap,because one uses so little.Disadvantages: Low volatility, slow onset of effectbecause of high blood solubility and low boil<strong>in</strong>g po<strong>in</strong>tmak<strong>in</strong>g it impossible to get concentrations that are highenough. It is a potent agent because you need little toproduce an effect, BUT it is a weak anaesthetic because,despite this, vaporisers cannot produce high enoughconcentrations because the volatility is so low. Tachypnoeaused to be reported <strong>in</strong> the West but we don’t see it <strong>in</strong>Malawi. Dysrhythmias may occur with adrenal<strong>in</strong>e.Prolonged recovery, because of high blood solubility.Indications: analgesic supplement to halothane or usedon its own for m<strong>in</strong>or procedures such as fracturemanipulation, debridement etc.Contra<strong>in</strong>dications: overdosage <strong>in</strong> the elderly. Closedcircuit with soda-lime. Best avoided <strong>in</strong> very small babies.Dosage: 0.5 - 1% <strong>in</strong>itially, reduc<strong>in</strong>g to 0.2 - 0.5%.Practice Po<strong>in</strong>ts: Switch off 20-30 m<strong>in</strong>utes before theend of a long operation to avoid prolonged sedative effects.Its ideal function is to give background analgesia for longcases us<strong>in</strong>g halothane as the ma<strong>in</strong> anaesthetic but it is alsovery good given with halothane for a fast turn-over of shortcases us<strong>in</strong>g <strong>in</strong>halation <strong>in</strong>duction. We give it from a Goldmanhalothane vaporiser <strong>in</strong> series with a halothane vaporiser,us<strong>in</strong>g a gauze <strong>in</strong> the bowl to <strong>in</strong>crease evaporation. Thisgives about 0.7%.The newer agents:Enflurane: was a replacement for halothane, now used<strong>in</strong>frequently.Isoflurane: Boils at 48 o C. SVP at 20 o C: 250mmHg,Blood/Gas partition coefficient: 1.4, MAC: 1.15. Ingeneral use, good recovery because of relatively low bloodsolubility, but <strong>in</strong>duction difficult because of irritat<strong>in</strong>g badsmell, m<strong>in</strong>imal metabolism, no arrhythmias but causeshypotension, six times the cost of halothane. Big costreductions when used <strong>in</strong> a low flow system.Desflurane: Boils at 23.5 o C, SVP at 20 o C: 673 mmHg,Blood/Gas partition coefficient 0.4 (low), MAC: 5-10%.Replacement for enflurane, requires a specially designedvaporiser, has come and gone without me ever see<strong>in</strong>g it!Sevoflurane: Boils at 58.5 o C, SVP at 20 o C: 160 mmHg,Blood/Gas partition coefficient 0.6 (low), MAC: 1.7-2%.Fabulously expensive ($1000/litre), but costs can bereduced if used <strong>in</strong> a low flow system. There may beproblems with sevoflurane and carbon dioxide absorbers,baralyme <strong>in</strong> particular, but these are currently be<strong>in</strong>g<strong>in</strong>vestigated. Ultra low solubility result<strong>in</strong>g <strong>in</strong> ultra rapid<strong>in</strong>duction and recovery especially as it is non-irritant andsweet smell<strong>in</strong>g. High volatility and high percentage required.How should volatile agents be used?One way is to use them for <strong>in</strong>halation <strong>in</strong>duction ofanaesthesia followed by ma<strong>in</strong>tenance with the same oranother agent as your sole anaesthetic. The patient putshim or herself to sleep by breath<strong>in</strong>g via a close-fitt<strong>in</strong>g maskand provided the smell is accepted and the stage IIexcitement effects are not excessive, this is a verysatisfactory method of <strong>in</strong>duc<strong>in</strong>g general anaesthesia form<strong>in</strong>or cases without gastric aspiration risk. Lung disease,smok<strong>in</strong>g or dr<strong>in</strong>k<strong>in</strong>g habit, obesity and high uptakesituations (see above) will make this method slower andprolong stage II effects. Loss of airway <strong>in</strong> an obese patientmay be dangerous. Ideal for a fast turn-over of lots ofshort procedures on th<strong>in</strong> patients.The other way is to put up a drip and give an <strong>in</strong>travenous<strong>in</strong>duction followed by the volatile agent for ma<strong>in</strong>tenanceof anaesthesia. Very often the <strong>in</strong>travenous <strong>in</strong>duction will<strong>in</strong>clude <strong>in</strong>tubation of the trachea as well. All generalanaesthesia for major cases will be done this way.Further read<strong>in</strong>g1. Scurr C, Feldman S, Soni N. Scientific Foundations of<strong>Anaesthesia</strong>. Fourth Edition. Oxford: He<strong>in</strong>emann Medical Books19912. Fenton, P. M. Epidemiology of district surgery <strong>in</strong> Africa. Eastand Central African Journal of Surgery. 1997;3:33-41.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!